1-1 of 1
Karen W.L. WL Yee, MD
Close
Sort by
Journal Articles

A Phase II Study Of Aprepitant As Anti-Emetic Prophylaxis In Patients Receiving Induction Chemotherapy For AML

Joseph Brandwein, MD, FRCPC, Karen W.L. WL Yee, MD, Andre C Schuh, MD, Vikas Gupta, MD, FRCP, FRCPath, Jack T Seki, PharmD
Journal: Blood
Blood (2013) 122 (21): 5035.
https://doi.org/10.1182/blood.V122.21.5035.5035
Published: 2013